The number of cancer survivors in the U.S. has risen and is likely to continue to rise, according to a report from researchers at the National Cancer Institute in Rockville, Md., published July 13 in the Journal of the National Cancer Institute. 

The Ohio State University Wexner Medical Center in Columbus has partnered with population genomics company Helix to launch the largest precision health initiative in the state.

The U.S. News & World Report's "2024-25 Best Hospitals for Cancer" ranked the top cancer centers in every state. 

There is a gender divide in oncologist net worth, according to the "Physician Wealth & Debt Report" published July 19 by Medscape.

The Fox Chase Cancer Center in Philadelphia has promoted Sanjay Reddy, MD, to surgical oncology division chief.

Researchers at the Yale School of Medicine in New Haven, Conn., found a Trojan horse therapy to be effective against a variety of cancerous tumors, including difficult-to-reach brain tumors, in a laboratory setting, according to a study published July 15 in ACS Central Science.

The growing popularity of Ozempic and other GLP-1s in recent years is garnering greater attention from oncologists interested in how these drugs could affect cancer care and cancer rates.

A recent survey found 62% of pulmonologists said they order biomarker testing for non-small cell lung cancer patients. Among those who said they do not order such testing, 84% said the reason is they believe it is the oncologist's responsibility, according to a study published June 19 in CHEST Journal.

The highest numbers of breast and cervical cancer deaths are found mostly in southeastern states, according to new data from the "2024 State Scorecard on Women’s Health and Reproductive Care" released July 18 by The Commonwealth Fund.

The drug cyclophosphamide prevented bone marrow transplant complications for patients with "mismatched" donors, according to a study published July 17 in the Journal of Clinical Oncology.

Existing screening protocols in place are failing to identify patients who might be carriers of a genetic mutation that is linked to certain cancers, according to Mayo Clinic researchers. 

An EHR reminder, or "nudge," can reduce unnecessary breast cancer surgeries, according to a study published July 17 in JAMA Surgery.

Eugene Kim, MD, has been named surgeon-in-chief and associate director of surgery at Torrance, Calif.-based Cedars-Sinai Guerin Children's.

A University of California Irvine study reported 90% patient satisfaction in cancer patients who were offered a multilanguage electronic tool to report their symptoms.

A clinical trial conducted by researchers at Rochester, Minn.-based Mayo Clinic and Minneapolis-based University of Minnesota found drug combinations eliminated or shrunk tumors in 70% of clinical trial participants with stage 3 melanoma. 

The FDA has given fast-track designation to Diakonos Oncology for its pancreatic cancer vaccine.

Tampa (Fla.) General Hospital has received a "substantial" gift to develop a center of colorectal cancer excellence. 

The median compensation for hematologists and medical oncologists increased 7.1% from 2023 to 2024, going from $498,062 to $533,402, according to the American Medical Group Association.

A University of Cambridge poll found 70% of people fear a late cancer diagnosis.

Cancer Resource Center of the Finger Lakes has affiliated with Ithaca, N.Y.-based Cayuga Health System, effective July 1.